These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7861415)

  • 1. Synthesis, structure-activity relationships, and pharmacological evaluation of pyrrolo[3,2,1-ij]quinoline derivatives: potent histamine and platelet activating factor antagonism and 5-lipoxygenase inhibitory properties. Potential therapeutic application in asthma.
    Paris D; Cottin M; Demonchaux P; Augert G; Dupassieux P; Lenoir P; Peck MJ; Jasserand D
    J Med Chem; 1995 Feb; 38(4):669-85. PubMed ID: 7861415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sch 37370: a new drug combining antagonism of platelet-activating factor (PAF) with antagonism of histamine.
    Billah MM; Chapman RW; Watnick AS; Egan RW; Siegel MI; Kreutner W
    Agents Actions Suppl; 1991; 34():313-21. PubMed ID: 1793070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.
    Carceller E; Merlos M; Giral M; Balsa D; Almansa C; Bartrolí J; García-Rafanell J; Forn J
    J Med Chem; 1994 Aug; 37(17):2697-703. PubMed ID: 7914928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sch 37370: a potent, orally active, dual antagonist of platelet-activating factor and histamine.
    Billah MM; Chapman RW; Egan RW; Gilchrest H; Piwinski JJ; Sherwood J; Siegel MI; West RE; Kreutner W
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1090-6. PubMed ID: 2319461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and preliminary pharmacology of Sch 37370, a dual antagonist of PAF and histamine.
    Billah MM; Egan RW; Ganguly AK; Green MJ; Kreutner W; Piwinski JJ; Siegel MI; Villani FJ; Wong JK
    Lipids; 1991 Dec; 26(12):1172-4. PubMed ID: 1819703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antagonistic effects of khellactones on platelet-activating factor, histamine, and leukotriene D4.
    Aida Y; Kasama T; Takeuchi N; Tobinaga S
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):859-67. PubMed ID: 7553972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig.
    Anderson GP; Fennessy MR
    Agents Actions Suppl; 1988; 23():195-200. PubMed ID: 3140616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
    Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
    J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist.
    Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G
    J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds.
    Hogaboam CM; Donigi-Gale D; Shoupe TS; Bissonnette EY; Befus AD; Wallace JL
    Br J Pharmacol; 1992 Jan; 105(1):87-92. PubMed ID: 1596692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipoxygenase metabolites in platelet-activating factor- and antigen-induced bronchial hyperresponsiveness and eosinophil infiltration.
    Seeds EA; Kilfeather S; Okiji S; Schoupe TS; Donigi-Gale D; Page CP
    Eur J Pharmacol; 1995 Dec; 293(4):369-76. PubMed ID: 8748690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.
    Anderson G; Fennessy M
    Br J Pharmacol; 1988 Aug; 94(4):1115-22. PubMed ID: 3145088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives.
    Cooper K; Fray MJ; Parry MJ; Richardson K; Steele J
    J Med Chem; 1992 Aug; 35(17):3115-29. PubMed ID: 1507200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and platelet-activating factor (PAF)-antagonistic activities of 1,4-disubstituted piperazine derivatives.
    Fukushi H; Mabuchi H; Itoh K; Terashita Z; Nishikawa K; Sugihara H
    Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):541-50. PubMed ID: 8004699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiallergic effect of epinastine (WAL 801 CL) on immediate hypersensitivity reactions: (II). Antagonistic effect of epinastine on chemical mediators, mainly antihistaminic and anti-PAF effects.
    Kamei C; Mio M; Kitazumi K; Tsujimoto S; Yoshida T; Adachi Y; Tasaka K
    Immunopharmacol Immunotoxicol; 1992; 14(1-2):207-18. PubMed ID: 1350791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition by azelastine of the effects of platelet-activating factor in lungs from actively sensitised guinea-pigs.
    Pretolani M; Lefort J; Venco C; Perrisoud D; Vargaftig BB
    Eur J Pharmacol; 1992 Jun; 216(2):141-7. PubMed ID: 1397002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of cutaneous vascular permeability induced by platelet-activating factor in guinea pigs and rats and its inhibition by a platelet-activating factor receptor antagonist.
    Hwang SB; Li CL; Lam MH; Shen TY
    Lab Invest; 1985 Jun; 52(6):617-30. PubMed ID: 3925239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacology of a potent platelet-activating factor antagonist: Ro 24-4736.
    Crowley HJ; Yaremko B; Selig WM; Janero DR; Burghardt C; Welton AF; O'Donnell M
    J Pharmacol Exp Ther; 1991 Oct; 259(1):78-85. PubMed ID: 1656030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.